Corporate News     28-May-22
Board of Astrazeneca Pharma India recommends Final Dividend
Of Rs.4 per share
Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 27 May 2022, has recommended a Final dividend of Rs.8 per share (i.e.400%), subject to the approval of the shareholders.
Previous News
  AstraZeneca Pharma India appoints director
 ( Corporate News - 13-Aug-20   10:21 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 26-Nov-21   11:00 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 24-Sep-24   12:00 )
  AstraZeneca receives import and market permission for Acalabrutinib 100mg capsules
 ( Corporate News - 13-Mar-20   10:07 )
  Astrazeneca Pharma India reports standalone net profit of Rs 0.79 crore in the September 2016 quarter
 ( Results - Announcements 11-Nov-16   16:06 )
  Astrazeneca Pharma India standalone net profit rises 204.97% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:13 )
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 17-Aug-18   12:56 )
  AstraZeneca Pharma tanks on reverse turnaround in Q3
 ( Hot Pursuit - 06-Feb-18   11:30 )
  Astrazeneca Pharma India reports net loss of Rs 1.23 crore in the September 2013 quarter
 ( Results - Announcements 16-Nov-13   15:03 )
  Astrazeneca Pharma India reports net profit of Rs 1.77 crore in the June 2013 quarter
 ( Results - Announcements 15-Aug-13   10:49 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 24-Sep-24   14:30 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top